These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11495389)

  • 21. Dementia with parkinsonism: what is the diagnosis?
    Chong MS; Vinters HV; Gustavson AR; Cummings JL
    Rev Neurol Dis; 2004; 1(1):41-4. PubMed ID: 16397452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dementia medications in palliative care #174.
    Morrison LJ; Liao S
    J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
    [No Abstract]   [Full Text] [Related]  

  • 23. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease].
    Krüger R; Weiss D
    MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
    Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current therapy of patients with dementia].
    Fuchsberger T; Möller HJ; Hampel H
    MMW Fortschr Med; 2003 May; 145 Suppl 2():49-52, 54. PubMed ID: 14579485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mild cognitive impairment in clinical practice].
    Olazarán Rodríguez J; Bermejo Pareja F
    Med Clin (Barc); 2011 Oct; 137(9):414-8. PubMed ID: 21163505
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological approaches to the therapy of Alzheimer's disease].
    Gavrilova SI
    Vestn Ross Akad Med Nauk; 2006; (9-10):30-4. PubMed ID: 17111921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan.
    Wu CY; Hu HY; Chow LH; Chou YJ; Huang N; Wang PN; Li CP
    PLoS One; 2015; 10(6):e0130993. PubMed ID: 26098910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761.
    Hoerr R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S56-61. PubMed ID: 13130390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acetylcholinesterase inhibitors for dementia--an update].
    Anghelescu I; Heuser I
    MMW Fortschr Med; 2007 May; 149 Suppl 2():76-8. PubMed ID: 17724973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing and treating dementia in German primary and specialized care between 2011 and 2015
.
    Michalowsky B; Kostev K; Iliffe S; Hoffmann W; Bohlken J
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):301-309. PubMed ID: 29701170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Reisberg B; Schneider L; Doody R; Anand R; Feldman H; Haraguchi H; Kumar R; Lucca U; Mangone CA; Mohr E; Morris JC; Rogers S; Sawada T
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():8-18. PubMed ID: 9305508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dementia.
    Jones RW
    Scott Med J; 1997 Oct; 42(5):151-3. PubMed ID: 9836346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 36. Dementia experts are optimistic despite decline in hope for effective drugs.
    Hawkes N
    BMJ; 2013 Jul; 347():f4265. PubMed ID: 23818576
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lewy body dementia and Parkinson disease dementia].
    Meyniel C; Damier P
    Presse Med; 2007 Oct; 36(10 Pt 2):1485-90. PubMed ID: 17572053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between elderly suicide rates and the affordability of psychotropic drugs.
    Shah A; Bhatia G
    Int Psychogeriatr; 2009 Feb; 21(1):204-5. PubMed ID: 18634616
    [No Abstract]   [Full Text] [Related]  

  • 39. [When should the medication for dementia be stopped?].
    Pitkälä K
    Duodecim; 2003; 119(9):817-8. PubMed ID: 12815978
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence and correlates of psychotropic drug use in community-dwelling people with young-onset dementia: the NeedYD-study.
    Koopmans RT; Reinders R; van Vliet D; Verhey FR; de Vugt ME; Bor H; Bakker C
    Int Psychogeriatr; 2014 Dec; 26(12):1983-9. PubMed ID: 24411220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.